Advertisement
Fourth iteration of the guidelines focuses on high-risk patient identification and evidence on newer drugs
Guideline panel chair shares critical insights
A clinical hypertension specialist puts recommendations in context
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement